miR-200c was demonstrated to activate epithelial-mesenchymal transition (EMT) via directly targeting neural cell adhesion molecule 1 (NCAM1) in ICC (9). The gene discussed is NCAM1; the disease is intrahepatic cholangiocarcinoma.